Back to Top Skip to main content Skip to sub-navigation

Pandemic underscores MHS’ need for reform, McCaffery tells AMSUS

Army soldier gets nose swab Army Sgt. Toni-Moi Dewar, noncommissioned officer in charge of the Kenner Army Health Clinic’s Active Duty Clinic performs a COVID-19 swab of a soldier at Fort Lee in Virginia. (U.S. Army photo)

Recommended Content:

Military Health System Transformation | Coronavirus | COVID-19 Vaccine Efforts | Vaccine Trials | Getting the COVID-19 Vaccine | COVID-19 Vaccine Toolkit | COVID-19 Vaccine Toolkit

The Department of Defense is moving forward with its plans to integrate and optimize all Military Health System components after pausing to focus on national response to the COVID-19 pandemic, Assistant Secretary of Defense for Health Affairs Tom McCaffery announced Dec. 8 in remarks to the annual meeting of AMSUS, the Society of Federal Health Professionals.

“An important lesson learned as a result of the pandemic is that marshalling the Department’s vast medical assets to quickly respond to a requirement on the scale of a pandemic is challenging when those assets are separately managed by four distinct entities,” McCaffery told the military and federal medical professionals who attended the virtual meeting.

During his 2019 AMSUS speech he announced that he had asked MHS senior leadership to develop and codify a formal strategic framework to guide the integration and optimization of all MHS components. MHS senior leadership is composed of the Army, Navy, and Air Force surgeons general as well as the Joint Staff surgeon; the Defense Health Agency director; and the president of Uniformed Services University of the Health Sciences.

Before the COVID-19 pandemic, the MHS had embarked on reforms and initiatives to improve its medical support to the armed services.

Those reforms were intended to “develop a long-term strategic framework to help all MHS components to better coordinate and integrate their efforts and our shared mission of ensuring a ready medical force,” McCaffery said, but the pandemic forced a pause in several reform initiatives to ensure the MHS could properly focus on supporting the DOD and all government pandemic responses.

The MHS leadership team has resumed this effort to develop this long-term strategy, he noted. In November, the secretary “lifted the pause on activities supporting the transition of the management of all [Medical Treatment Facilities] MTFs from the services to the DHA and directed resumption of the department’s implementation plan to complete the transition by Sept. 30, 2021,” McCaffery said.

“The pandemic experience has underscored the need for a consolidated enterprise management of our health care system. Managing the department’s critical medical assets, under an enterprise framework, allows the health system to more effectively support the military departments’ man, train, and equip responsibilities that support a ready medical force,” he explained.

Having the private sector care under the TRICARE Health Plan and the DoD’s more than 700 military hospitals and clinics “under one joint agency will allow us to have standardized health care delivery policies and business practices across the entire military health system,” McCaffery said, “and that will go a long way to reducing undesirable variation for both providers and patients and improve our beneficiaries’ experience.”

The primary driver for this change is the National Defense Authorization Act of 2017. Congress mandated that a single agency will be responsible for the administration and management of all military hospitals and clinics to sustain and improve operational medical force readiness and the medical readiness of military members, improve beneficiaries' access to care and experience of care, improve health outcomes, and eliminate redundancies in medical costs and overhead across separate systems operated by the Army, Air Force and Navy.  DHA will be responsible for health care delivery and business operations across the Military Health System including budgets, information technology, health care administration and management, administrative policies and procedures, and military medical construction.

The impending COVID-19 vaccine distribution and administration effort is testament to the DHA’s increasing role in standardizing and coordinating military medical strategy and Direct CareDirect care refers to military hospitals and clinics, also known as “military treatment facilities” and “MTFs.”direct care.

On Nov. 3, the Secretary of Defense established a DOD COVID-19 Vaccine Distribution Operational Planning Team following release of the Trump Administration’s plan.

“The Defense Health Agency was directed in partnership with the Joint Staff to develop a standardized and coordinated strategy for prioritizing, distributing, and administering a COVID-19 pandemic vaccine through a phased approach to all active duty service members, their dependents and to all of our 9.6 million beneficiaries,” McCaffery said.

Military Health System dollars and people are central to the success of the government’s Operation Warp Speed to produce and deliver 300 million doses of safe and effective COVID-19 vaccines to the U.S., McCaffery explained.

McCaffery stated that the initial COVID-19 military vaccination efforts will focus on those “critical to the response, providing direct care, and maintaining societal mission-essential functions, as well as those at highest risk for developing severe illness.”

In the U.S., four companies are in clinical trials with vaccines to combat COVID-19 (Pfizer, Moderna, AstraZeneca and Janssen), and there are six vaccine candidates across three platforms: nucleic acid (Pfizer, Moderna), viral vector (AstraZeneca, Janssen) and protein sub-unit (Novavax, Sanofi).

One or two vaccines – from Pfizer and Moderna – are expected to be approved by the Food and Drug Administration soon. Both companies have applied for emergency use authorizations.

“Throughout this pandemic, the department must ensure we can continue to maintain its military readiness and ensure our national security,” McCaffery said. “As such, in addition to conducting clinical/diagnostic testing, the department established a tiered testing framework, that prioritizes testing service members and personnel associated with vital national security missions, our engaged field forces, and forward deployed or redeploying forces.”

That support also has included civilian health care facilities, especially in the hardest hit areas of the pandemic last spring and into the fall surge.

“From the onset of COVID-19, the department has mobilized more than 7,000 doctors, nurses, and medical technicians – both active duty and reserve – to support many civilian health systems, including deployment of military health care professionals in direct support of hospitals and alternate care facilities,” McCaffery said. “This support has been critical to the hardest-hit communities and enabled their hospitals to sustain operations in the midst of unprecedented demand for their services. These communities were in desperate need of help and it was the military health system that provided it.”

On a different front, MHS moved quickly to direct its medical research and development capability to support the national effort to respond to COVID-19, he noted.

“We leveraged our prior investments that built an infectious disease research, development, and manufacturing infrastructure and our ongoing research on medical countermeasures to support the all-of-government effort to develop and manufacture vaccines and therapeutics to fight the virus,” McCaffery said.

One of the first approved therapeutics for COVID-19, remdesivir, was part of a DOD-sponsored research effort. Five MTFs are enrolling for the AstraZeneca vaccine clinical trial. The DOD also is supporting the development of Inovio’s vaccine.

Another major initiative that has been resumed during the COVID-19 pandemic is the deployment of the unified electronic health record (EHR) system called MHS GENESIS.

“Like our broader reforms, MHS GENESIS represents a concerted push toward standardization, integration and readiness,” McCaffery told AMSUS. There have been three waves of implementation that have launched MHS GENESIS at 19 military medical treatment facility commands since its rollout in 2017. Five additional waves will Go-Live in 2021.

The Department of Veterans Affairs is deploying the same EHR, “ensuring a seamless transition for service members during their career and into retirement,” he noted.

You also may be interested in...

DHA-PI 6205.01: Medical Logistics Guidance for the DoD Coronavirus Disease 2019 (COVID-19) Vaccination Program

Policy

This Defense Health Agency-Procedural Instruction (DHA-PI), based on the authority of References (a) and (b), and in accordance with the guidance of References (c) through (n), establishes the Defense Health Agency's (DHA's) procedures for ordering, receiving, and managing COVID-19 Vaccines inventory and ancillary kits.

DHA-IPM 20-004: Department of Defense (DoD) Coronavirus Disease 2019 (COVID-19) Vaccination Program Implementation

Policy

This Defense Health Agency (DHA) Interim Procedures Memorandum (IPM), based on the authority of References (a) through (d), and in accordance with the guidance cited in References (e) through (aa), establishes the DHA’s procedures to implement instructions, assign responsibilities, and prescribe procedures for the COVID-19 Vaccination Program. This DHA-IPM applies to DHA, DHA Components (activities under the authority direction, and control of the DHA), Military Departments (MILDEP), and the United States Coast Guard (CG). This DHA-IPM cancels and replaces DHA-IPM 20-004, “Department of Defense (DoD) Coronavirus Disease 2019 (COVID-19) Vaccination Program Implementation,” December 13, 2020.

DHA COVID19 Medical Coding PolicyV5 1v

Policy

Establishes the DHA procedures to standardize the coding for Coronavirus 2019 (COVID-19) within military medical treatment facilities (MTFs). This memorandum replaces DHA-Policy Memorandum 20-003 of July 1, 2020. Attachment 1 was updated to include the 2021 procedure and diagnosis codes for COVID-19, including the new vaccination and treatment codes.

  • Identification #: 20-003
  • Date: 3/25/2021
  • Type: Memorandums
  • Topics: Coronavirus

TAB A MEO COVID19 Medical Coding Policy

Policy

Memorandum for DHA Staff - Military Medical Treatment Facilities to Implement Updated DHA COVID-19 Medical Coding Policy

  • Identification #: N/A
  • Date: 3/25/2021
  • Type: Memorandums
  • Topics: Coronavirus

Supplemental Guidance for Providing DoD Coronavirus Disease 2019 Vaccines to DoD Contractor Employees and Select Foreign Nationals

Policy

This memorandum provides supplemental guidance on the provision of coronavirus disease 2019 (COVID-19) vaccines, in accordance with reference (a). The Defense Health Agency (DHA) is the lead coordinating DoD Component for executing this guidance, in coordination with the Military Departments and other DoD Components as appropriate.

HA Guidance for Coronavirus Disease 2019 (COVID-19) Laboratory Pre-Testing Questionnaire

Policy

This memorandum provides guidance for a COVID-19 laboratory pre-testing questionnaire that will be mandatory for all Active Duty Service members and encouraged for all other DoD beneficiaries treated at military medical treatment facilities.

Executive Order on Ensuring Access to United States Government COVID-19 Vaccines

Policy

This EO outlines who should receive priority access to COVID-19 vaccines developed in the United States or procured by the United States Government (“United States Government COVID-19 Vaccines”).

Coronavirus Disease 2019 Vaccine Guidance

Policy

This memorandum provides guidance on the provision of coronavirus disease 2019 (COVID-19) vaccines. The Defense Health Agency (DHA) is the lead coordinating DoD Component for executing this guidance, in coordination with the Military Departments and other DoD Components.

DHA-AI 3020-01: Return to the Workplace Staffing Plan in the Coronavirus Disease 2019 Environment

Policy

This Defense Health Agency-Administrative Instruction (DHA-AI), based on the authority of References (a) through (b) and in accordance with the guidance of References (c) through (z3), establishes the Defense Health Agency's (DHA) plan to return to full operations and support the whole-of-government response, during the Coronavirus Disease 2019 (COVID-19) pandemic. This DHA-AI also provides a preventive plan to monitor and assess for the appearance of new cases and implement those processes that will prevent them from impacting the workforce. The processes describe herein are intended to offer an actionable plan for the workforce to re-enter DHA Administrative Offices. See Appendix 1 for a summary of the DHA Administrative Office Reopening Plan. The plan uses the Force Health Protection Guidance and Health Protection Conditions (HPCON), in accordance with Reference (d), to ensure protection for the workforce, including the most vulnerable-to-serious complications from the virus while enabling DHA Administrative Offices to continue its mission. See Appendix 2 for the conceptual HPCON framework.

  • Identification #: 3020-01
  • Date: 11/3/2020
  • Type: Administrative Instructions
  • Topics: Coronavirus

DHA AI 3020.01: Return to the Workplace Staffing Plan in the Coronavirus Disease 2019 (COVID-19) Environment

Policy

This Defense Health Agency-Administrative Instruction (DHA-AI), establishes the Defense Health Agency’s (DHA) plan to return to full operations and support the whole-of-government response, during the Coronavirus Disease 2019 (COVID-19) pandemic and in preparation for regression or resurgence in COVID-19 cases that could impact the workforce.

  • Identification #: DHA AI 3020.01
  • Date: 6/12/2020
  • Type: Administrative Instructions
  • Topics: Coronavirus

Continuing Implementation of the Reform of the Military Health System

Policy

This memorandum directs the continued implementation of the Military Health System (MHS) organizational reform required by 10 U.S.C. § 1073c, and sections 71 land 712 of the John S. McCain National Defense Authorization Act (NDAA) for Fiscal Year (FY) 2019. The DoD policy for this reform is guided by the goals of improved readiness, better health, better care, and lower cost. The Department will advance these objectives through specific organizational reforms directed by Congress and the continued direction of the Secretary of Defense·anct the National Defense Strategy.

Showing results 1 - 11 Page 1 of 1

DHA Address: 7700 Arlington Boulevard | Suite 5101 | Falls Church, VA | 22042-5101

Some documents are presented in Portable Document Format (PDF). A PDF reader is required for viewing. Download a PDF Reader or learn more about PDFs.